Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    cubist | Exclude Unknown | diarrhea
Show Display Options
Rank Status Study
1 Recruiting Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Condition: Clostridium Difficile Infection
Interventions: Drug: CB-183,315;   Drug: oral vancomycin
2 Recruiting A Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea
Condition: Clostridium Difficile Infection
Interventions: Drug: CB-183,315;   Drug: oral vancomycin
3 Recruiting Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
Condition: Clostridium Difficile-Associated Diarrhea (CDAD)
Interventions: Drug: fidaxomicin;   Drug: placebo
4 Completed Study of CB-183,315 in Patients With Clostridium Difficile Infection
Conditions: Clostridium Difficile Infection;   Diarrhea
Intervention: Drug: CB-183,315
5 Recruiting A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Condition: Clostridium Difficile-associated Diarrhea (CDAD)
Interventions: Drug: Fidaxomicin;   Drug: Vancomycin

Indicates status has not been verified in more than two years